國立高雄大學圖資館 |

Language: English

Back

Current advances in the science of o...

Gorlick, Richard.

Current advances in the science of osteosarcomaresearch perspectives : tumor biology, organ microenvironment, potential new therapeutic targets, and canine models /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Current advances in the science of osteosarcomaedited by Eugenie S. Kleinerman, Richard Gorlick.
Reminder of title:	research perspectives : tumor biology, organ microenvironment, potential new therapeutic targets, and canine models /
other author:	Kleinerman, Eugenie S.
Published:	Cham :Springer International Publishing :2020.
Description:	xiii, 233 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Osteosarcoma.
Online resource:	https://doi.org/10.1007/978-3-030-43085-6
ISBN:	9783030430856$q(electronic bk.)

Current advances in the science of osteosarcomaresearch perspectives : tumor biology, organ microenvironment, potential new therapeutic targets, and canine models /
Current advances in the science of osteosarcomaresearch perspectives : tumor biology, organ microenvironment, potential new therapeutic targets, and canine models /[electronic resource] :edited by Eugenie S. Kleinerman, Richard Gorlick. - Second edition. - Cham :Springer International Publishing :2020. - xiii, 233 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.12580065-2598 ;. - Advances in experimental medicine and biology ;946..

The genomic complexity of osteosarcoma and its implication for preclinical and clinical targeted therapies -- Genomics and the Immune Landscape of Osteosarcoma -- RECQ DNA Helicases and Osteosarcoma -- Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma -- Oncolytic viruses and their potential as a therapeutic opportunity in Osteosarcoma -- Applying Osteosarcoma Immunology to Understand Disease Progression and Assess immunotherapeutic Response -- Targetable intercellular signaling pathways facilitate lung colonization in osteosarcoma -- Wnt Signaling in Osteosarcoma -- Receptor Tyrosine Kinases in Osteosarcoma: 2019 update -- The Role of ALDH in the Metastatic Potential of Osteosarcoma Cells and Potential ALDH Targets -- Autophagy in OS -- Fas signaling as a potential target for the treatment of osteosarcoma metastasis in the lungs -- Exosomes: Dynamic Mediators of Extracellular Communication in the Tumor Microenvironment -- Comparative Immunology and Immunotherapy of Canine Osteosarcoma -- Index.

This thoroughly revised second edition is an up-to-date overview of the new advances in the knowledge of the basic science in sarcoma and osteosarcoma. It features detailed, in-depth discussions of microRNAs in osteosarcoma, historical perspectives of chemotherapy in the treatment of the disease, tumor targeted IL12 therapy and HER2 targeted therapy, the role of enhancer elements in regulating the prometastatic transcriptional program and more. Further, this essential volume also includes new insights on Wnt signaling in osteosarcoma, the role of genomics, genetically modified T-cell therapy, liquid biopsy, oncolytic viruses, immunophenotyping, receptor tyrosine kinases and epigenetic-focused approaches for treatment of osteosarcoma metastases, as well as thoughts on the current standard of treatment for patients suffering from these cancers. In the years since the previous edition, there have been numerous new developments in this rapidly changing field; this new edition is both timely and urgently needed. When taken together these companion volumes, Current Clinical (Book 1) and Scientific (Book 2) Advances in Osteosarcoma, are a timely and urgently needed guide for laboratory investigators and clinical oncologists.

ISBN: 9783030430856$q(electronic bk.)

Standard No.: 10.1007/978-3-030-43085-6doiSubjects--Topical Terms:

682735
Osteosarcoma.

LC Class. No.: RC280.B6 / C877 2020

Dewey Class. No.: 616.99471

Current advances in the science of osteosarcomaresearch perspectives : tumor biology, organ microenvironment, potential new therapeutic targets, and canine models /
LDR:03531nmm a2200349 a 4500 001 584968
003 DE-He213
005 20201210160825.0
006 m d
007 cr nn 008maaau
008 210311s2020 sz s 0 eng d
020 $a 9783030430856$q(electronic bk.)
020 $a 9783030430849$q(paper)
024 7 $a 10.1007/978-3-030-43085-6 $2 doi
035 $a 978-3-030-43085-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B6 $b C877 2020
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99471 $2 23
090 $a RC280.B6 $b C976 2020
245 0 0 $a Current advances in the science of osteosarcoma $h [electronic resource] : $b research perspectives : tumor biology, organ microenvironment, potential new therapeutic targets, and canine models / $c edited by Eugenie S. Kleinerman, Richard Gorlick.
250 $a Second edition.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a xiii, 233 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1258
505 0 $a The genomic complexity of osteosarcoma and its implication for preclinical and clinical targeted therapies -- Genomics and the Immune Landscape of Osteosarcoma -- RECQ DNA Helicases and Osteosarcoma -- Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma -- Oncolytic viruses and their potential as a therapeutic opportunity in Osteosarcoma -- Applying Osteosarcoma Immunology to Understand Disease Progression and Assess immunotherapeutic Response -- Targetable intercellular signaling pathways facilitate lung colonization in osteosarcoma -- Wnt Signaling in Osteosarcoma -- Receptor Tyrosine Kinases in Osteosarcoma: 2019 update -- The Role of ALDH in the Metastatic Potential of Osteosarcoma Cells and Potential ALDH Targets -- Autophagy in OS -- Fas signaling as a potential target for the treatment of osteosarcoma metastasis in the lungs -- Exosomes: Dynamic Mediators of Extracellular Communication in the Tumor Microenvironment -- Comparative Immunology and Immunotherapy of Canine Osteosarcoma -- Index.
520 $a This thoroughly revised second edition is an up-to-date overview of the new advances in the knowledge of the basic science in sarcoma and osteosarcoma. It features detailed, in-depth discussions of microRNAs in osteosarcoma, historical perspectives of chemotherapy in the treatment of the disease, tumor targeted IL12 therapy and HER2 targeted therapy, the role of enhancer elements in regulating the prometastatic transcriptional program and more. Further, this essential volume also includes new insights on Wnt signaling in osteosarcoma, the role of genomics, genetically modified T-cell therapy, liquid biopsy, oncolytic viruses, immunophenotyping, receptor tyrosine kinases and epigenetic-focused approaches for treatment of osteosarcoma metastases, as well as thoughts on the current standard of treatment for patients suffering from these cancers. In the years since the previous edition, there have been numerous new developments in this rapidly changing field; this new edition is both timely and urgently needed. When taken together these companion volumes, Current Clinical (Book 1) and Scientific (Book 2) Advances in Osteosarcoma, are a timely and urgently needed guide for laboratory investigators and clinical oncologists.
650 0 $a Osteosarcoma. $3 682735
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Medical Microbiology. $3 273931
650 2 4 $a Cell Biology. $3 274165
650 2 4 $a Pediatrics. $3 274247
700 1 $a Kleinerman, Eugenie S. $3 868781
700 1 $a Gorlick, Richard. $3 868782
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-3-030-43085-6
950 $a Biomedical and Life Sciences (SpringerNature-11642)